Carmel van den Berk built her path through structural-heart MedTech operations, healthcare strategy, and both early- and growth-stage healthcare investing before becoming Principal at Brightlands Venture Partners, and her health economics background shows up in how closely she looks at affordability, access, and pressure on health systems rather than just product novelty. She also holds a stricter view of what counts as impact investing in health than many peers, looks closely at what makes healthcare AI last beyond hype, such as proprietary data, regulatory positioning, and workflow integration, and speaks publicly about how MedTech companies can be built in ways that make them attractive to acquirers as diligence standards increase.